-
China Unveils 2024 Plan to Combat Fraud in Medical Insurance Funds
•
The National Healthcare Security Administration (NHSA) of China, in conjunction with the Supreme People’s Court, the Supreme People’s Procuratorate, the Ministry of Public Security, the Ministry of Finance, and the National Health Commission, has unveiled the “2024 Special Work Plan for the Rectification of Illegal and Non-compliant Issues Related to…
-
Chinese Authorities Launch Special Plan to Rectify Medical Insurance Fraud and Non-Compliance
•
The National Healthcare Security Administration (NHSA) of China, in collaboration with the Supreme People’s Court, Supreme People’s Procuratorate, Ministry of Public Security, Ministry of Finance, and National Health Commission, has jointly issued the “2024 Special Work Plan for the Rectification of Illegal and Non-compliant Issues Related to Medical Insurance Funds.”…
-
China’s New Drug Quality Management Measures to Take Effect in 2024
•
The State Administration for Market Regulation (SAMR) has released the “Drug Operation and Use Quality Administration and Management Measures,” set to take effect from January 1, 2024. These measures will apply to the quality management and supervision of drug operation, use, and management activities within China, ensuring stringent standards for…
